MeVis Medical Solutions AG reported earnings results for the third quarter and nine months ended June 30, 2018. Sales in the third quarter of fiscal 2018 came to EUR 3,900,000, about 12% below EUR 4,400,000 reported in the previous year. EBIT (earnings before financial result and taxes) of EUR 1,304,000 was generated in the third quarter compared to EUR 1,717,000 in the previous year's period. Earnings after taxes amounted to EUR 5,122,000 against previous year's EUR 3,967,000, which corresponds to undiluted earnings per share of EUR 2.81 against previous year's EUR 2.18.

Revenues thus amounted to EUR 12,133,000 in the first nine months of the year, against EUR 14,196,000 for the same period a year ago, which EUR 8,192,000 was attributable to the Digital Mammography segment against previous year's EUR 8,984,000 and EUR 3,941,000 to Other Diagnostics against previous year's EUR 5,212,000. EBIT (earnings before financial result and taxes) of EUR 4,440,000 in the first nine months of fiscal 2018, compared to EUR 5,327,000 in the previous year's period.

For the year 2018 a significant decrease in revenues to EUR 16.0 million to EUR 16.5 million is now expected (previous forecast for fiscal year 2018: significant decrease to EUR 14.5 million to EUR 15.0 million). For fiscal year 2018 a significant decrease in the EBIT (earnings before interest and taxes) is expected to EUR 5.5 million to EUR 6.0 million (previous forecast for fiscal year 2018: decrease in EBIT to EUR 3.0 million to EUR 3.5 million).